Get the Stockscreener App
1.3377
0.91%
-0.0123
After Hours:
1.34
0.0023
+0.17%
Intercure Ltd stock is traded at $1.3377, with a volume of 2,323.
It is down -0.91% in the last 24 hours and down -7.10% over the past month.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
See More
Previous Close:
$1.35
Open:
$1.3377
24h Volume:
2,323
Relative Volume:
0.04
Market Cap:
$73.82M
Revenue:
$118.18M
Net Income/Loss:
$5.99M
P/E Ratio:
10.14
EPS:
0.1319
Net Cash Flow:
$-12.91M
1W Performance:
+2.04%
1M Performance:
-7.10%
6M Performance:
-12.57%
1Y Performance:
-0.91%
1-Day Range:
$1.3377
$1.3377
1-Week Range:
$1.29
$1.35
52-Week Range:
$1.22
$1.79
Intercure Ltd Stock (INCR) Company Profile
Compare INCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INCR
Intercure Ltd
|
1.3377 | 73.82M | 118.18M | 5.99M | -12.91M | 0.1319 |
|
ZTS
Zoetis Inc
|
128.18 | 56.27B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.42 | 45.87B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.78 | 43.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
26.89 | 30.20B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
486.00 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-22 | Upgrade | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd Stock (INCR) Latest News
US Market Wrap: Can InterCure Ltd. stock deliver sustainable ROEJuly 2025 Intraday Action & Weekly Setup with ROI Potential - moha.gov.vn
InterCure Ltd. Schedules Annual General Meeting for December 2025 - TipRanks
[6-K] Intercure Ltd. Current Report (Foreign Issuer) | INCR SEC FilingForm 6-K - Stock Titan
Intercure schedules annual shareholder meeting for December 30 in Tel Aviv - Investing.com
InterCure (NASDAQ:INCR) Shares Up 0.7% – Time to Buy? - Defense World
How InterCure Ltd. stock performs during Fed tightening cyclesWeekly Trading Summary & High Accuracy Trade Alerts - newser.com
Why InterCure Ltd. stock remains undervaluedJuly 2025 Market Mood & Momentum Based Trading Ideas - newser.com
How InterCure Ltd. stock performs in weak economyMarket Activity Recap & Accurate Intraday Trading Signals - newser.com
Can InterCure Ltd. stock beat market expectations this quarterJuly 2025 EndofMonth & Fast Momentum Entry Tips - newser.com
Is it time to cut losses on InterCure Ltd.Earnings Growth Report & Weekly Breakout Stock Alerts - newser.com
Is InterCure Ltd. stock a buy in volatile marketsIndex Update & Advanced Swing Trade Entry Plans - newser.com
How strong is InterCure Ltd. stock revenue growthJuly 2025 Setups & Daily Stock Trend Watchlist - newser.com
Is InterCure Ltd. stock cheap at current valuationJuly 2025 Decliners & Weekly Top Performers Watchlists - newser.com
Will InterCure Ltd. stock recover after recent dropWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com
Does InterCure Ltd. stock trade at a discount to peersLayoff News & Long-Term Growth Stock Strategies - newser.com
Will InterCure Ltd. stock sustain high P E ratiosJuly 2025 Review & Technical Analysis for Trade Confirmation - newser.com
Will InterCure Ltd. stock outperform international peersJuly 2025 Analyst Calls & Scalable Portfolio Growth Ideas - newser.com
Will InterCure Ltd. price bounce be sustainableInflation Watch & AI Forecasted Stock Moves - newser.com
What drives InterCure Ltd stock priceMarket Sentiment Extremes & Low Entry Capital Stocks - earlytimes.in
Will InterCure Ltd. stock benefit from green energy trendsJuly 2025 Outlook & Consistent Profit Alerts - newser.com
What insider trading reveals about InterCure Ltd. stockJuly 2025 Final Week & High Accuracy Trade Signal Alerts - newser.com
Real time scanner hits for InterCure Ltd. explainedJuly 2025 Short Interest & Weekly Chart Analysis and Guides - newser.com
News impact scoring models applied to InterCure Ltd.2025 Retail Activity & High Yield Stock Recommendations - newser.com
What technical charts say about InterCure Ltd. stockEarnings Beat & Risk Controlled Stock Alerts - newser.com
Does InterCure Ltd. qualify in momentum factor screening2025 Macro Impact & Verified Momentum Stock Ideas - newser.com
Technical signs of recovery in InterCure Ltd.Earnings Trend Report & Precise Trade Entry Recommendations - newser.com
Intercure Ltd Stock (INCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.54%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):